Exelixis
EXEL
#1801
Rank
โ‚ฌ9.49 B
Marketcap
35,28ย โ‚ฌ
Share price
0.78%
Change (1 day)
4.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company